Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.

Authors :: Walter HS
Jayne S
Rule SA
Cartron G
Morschhauser F
Macip S
Karlin L
Jones C
Herbaux C
Quittet P
Shah N
Hutchinson CV
Fegan C
Yang Y
Mitra S
Salles G
Dyer MJS
Source :: Blood [Blood] 2017 May 18; Vol. 129 (20), pp. 2808-2810. Date of Electronic Publication: 2017 Apr 04.
Publication Year :: 2017

Subjects :: Agammaglobulinaemia Tyrosine Kinase
Disease-Free Survival
Female
Follow-Up Studies
Humans
Imidazoles adverse effects
Leukemia, Lymphocytic, Chronic, B-Cell epidemiology
Male
Pyrimidines adverse effects
Survival Rate
Imidazoles administration & dosage
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell mortality
Protein-Tyrosine Kinases antagonists & inhibitors
Pyrimidines administration & dosage

Full Text Access

Tools